Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...

Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...

Hypertrophic cardiomyopathy (HCM) causes heart muscle thickening that may lead to obstructed blood flow. Symptoms include ...

American Heart Month may be over, but experts still want to bring awareness to a condition that many people may have without even knowing it.

A new study has uncovered that a gene variant common in Oceanian communities was misclassified as a potential cause of heart ...

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

Genetic testing for hereditary arrhythmia and cardiomyopathy in an area with known founder effects on local genetic variants ...

Researchers at St. Jude Children’s Research Hospital identified a panel of 27 serum proteins that accurately predicted ...

A 12-week supervised high-intensity exercise programme was feasible for patients with hypertrophic cardiomyopathy (HCM), leading to potential improvements in cardiorespiratory fitness ...

Heart issues around pregnancy can be life-threatening, but they're often missed. Two moms share their experiences and the doctor making sure more women survive.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Diabetic cardiomyopathy (DCM), ...

Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.